Oxford Biomedica plc (LON:OXB - Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 421.03 ($5.25) and traded as high as GBX 427.50 ($5.33). Oxford Biomedica shares last traded at GBX 423 ($5.28), with a volume of 114,411 shares changing hands.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft upped their target price on shares of Oxford Biomedica from GBX 250 ($3.12) to GBX 380 ($4.74) and gave the stock a "hold" rating in a research note on Tuesday, September 24th.
View Our Latest Stock Analysis on Oxford Biomedica
Oxford Biomedica Stock Down 1.8 %
The business has a 50-day simple moving average of GBX 420.59 and a 200-day simple moving average of GBX 376.82. The company has a debt-to-equity ratio of 154.88, a quick ratio of 1.67 and a current ratio of 2.35. The company has a market cap of £437.77 million, a price-to-earnings ratio of -288.54 and a beta of 1.09.
About Oxford Biomedica
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Further Reading
Before you consider Oxford Biomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.
While Oxford Biomedica currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
